An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models.

Poirier D, Roy J, Maltais R, Weidmann C, Audet-Walsh É

Open source

DOI
10.3390/cancers15113033
Published
2023 Jun 2
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers15113033,
  title = {An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models.},
  author = {Poirier D and Roy J and Maltais R and Weidmann C and Audet-Walsh É},
  year = {2023},
  journal = {Cancers},
  doi = {10.3390/cancers15113033},
  url = {https://doi.org/10.3390/cancers15113033}
}

RIS

TY  - JOUR
TI  - An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models.
AU  - Poirier D
AU  - Roy J
AU  - Maltais R
AU  - Weidmann C
AU  - Audet-Walsh É
PY  - 2023
JO  - Cancers
DO  - 10.3390/cancers15113033
UR  - https://doi.org/10.3390/cancers15113033
ER  - 

APA

D, P., J, R., R, M., C, W., & É, A. (2023). An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models.. Cancers. https://doi.org/10.3390/cancers15113033

Source records